 |
Legislation
Decree
Decree
nº 3.181, of September 23, 1999
|
Regulates
Law nº 9.787, of February 10, 1999, concerning Sanitary
Surveillance, establishes the generic medicine, and decides
upon the use of generic names in pharmaceutical products,
among other procedures.
| |
The
PRESIDENT OF THE REPUBLIC, in the use of the attribution vested in him under article
84, item IV of the Constitution, and, in view of provisions in article 57, of
Law No. 6.360, of September 23 ,1976 and in article 4, of Law No. 9.787, of February
10,1999, DECREES: Article
1 - The terminology of the Brazilian Common Denomination - DCB or, in its absence,
the International Nonproprietary Name - INN, must be used in all packaging, labels,
leaflets, handouts, texts, or in any other type of marketing and medical information
material referring to medicines. Article
2 - The generic denomination of the medicines must be placed in the same printing
field and below the trade mark. Article
3 - The lettering used must maintain due proportion in terms of distance between
letters, with a view to easy reading and highlighting, especially with respect
to generic denomination for the base substance, which should correspond to half
the size of the letters and characters of the trade mark. Article
4 - The cartoon used in the packaging of medicines, dietetic products and related
products which can only be sold under medical prescription, should have a red
strip in all of its extension, in its bottom middle third part, its placement
at the bottom of the packaging being forbidden, its width not inferior to one
fifth of the largest total face, containing the statement: "Sold under medical
prescription." Article
5 - Whenever the medicine contains an association or combination of active principles
in a fixed dose, the National Sanitary Surveillance Agency, by means of an administrative
deed, shall determine the correspondences with the generic denomination. Article
6 - The use of the generic denomination in the forms or registration requests
and authorizations related to the production, trade and importation of medicines
is mandatory. Article
7 - The laboratories currently producing and trading medicines with or without
trade mark shall be granted a four-month period to carry out alterations and adaptations
need to comply with provisions stated in Law No. 9.787, of February 10, 1999 and
in this Decree. Only Paragraph. The so-called "similar" medicine
shall only be traded and identified by its trade mark. Article
8 - The Sanitary Surveillance Agency shall regulate the labeling criteria regarding
the Brazilian Common Denomination - DCB in all medicines, following the provisions
of articles 3 and 5 of this Decree. Article
9 - This Decree enters into force on the date of its publication. Article
10 - Decree No. 793, of April 5, 1993 is hereby revoked. Brasília,
September 23rd 1999; 178th day of the Independence and 111th of the Republic. Fernando
Henrique Cardoso José
Serra
|
|